Virtual cancer clinic Perci Health has secured £3 million in new funding, bringing its total raised to £7.7 million. The round, which doubled its initial £1.5 million target, included £295,000 from Macmillan Cancer Support, alongside participation from Guinness Ventures and Conduit Fund. Existing investors Octopus Ventures and 35 UK-based oncologists and cancer surgeons also contributed.
Perci Health delivers AI-enabled, multidisciplinary cancer care spanning prevention, treatment, recovery, and survivorship. Its model combines digital tools with specialist input from nurses, dietitians, physiotherapists, psychologists and others to support patients throughout their cancer journey.
The company is led by an all-female founding team and has a leadership structure that is majority female. It has consistently raised twice the average deal size for UK female-led startups in each of its rounds, despite structural funding disparities in the sector.
Perci’s services are designed to fill long-standing gaps in UK cancer care, where outcomes lag up to 25 years behind European peers. In England, 41 per cent of staged diagnoses are at a late stage, and screening uptake remains suboptimal.
The new capital will support Perci’s expansion across insurers and employers, helping working-age individuals affected by cancer regain independence and financial stability. Its platform aims to address rising survivorship needs with scalable, specialist-led care that improves patient outcomes and supports broader efforts to reduce health-related economic inactivity.
Perci Health’s team of over 85 specialists is focused on delivering long-term, cost-efficient cancer care through its AI-native digital model.
